This study tested the hypothesis that in vivo norepinephrine (NE) treatment induces bimodal cardiac functional protection against ischemia and examined the roles of ₁-adrenoceptors, protein kinase C (PKC), and cardiac gene expression in cardiac protection. Rats were treated with NE (25 µg/kg iv). Cardiac functional resistance to ischemia-reperfusion (25/40 min) injury was examined 30 min and 1, 4, and 24 h after NE treatment with the Langendorff technique, and effects of ₁-adrenoceptor antagonism and PKC inhibition on the protection were determined. Northern analysis was performed to examine cardiac expression of mRNAs encoding -actin and myosin heavy chain (MHC) isoforms. Immunofluorescent staining was performed to localize PKC-I in the ventricular myocardium. NE treatment improved postischemic functional recovery at 30 min, 4 h, and 24 h but not at 1 h. Pretreatment with prazosin or chelerythrine abolished both the early adaptive response at 30 min and the delayed adaptive response at 24 h. NE treatment induced intranuclear translocation of PKC-I in cardiac myocytes at 10 min and increased skeletal -actin and -MHC mRNAs in the myocardium at 4-24 h. These results demonstrate that in vivo NE treatment induces bimodal myocardial functional adaptation to ischemia in a rat model. ₁-Adrenoceptors and PKC appear to be involved in signal transduction for inducing both the early and delayed adaptive responses. The delayed adaptive response is associated with the expression of cardiac genes encoding fetal contractile proteins, and PKC-I may transduce the signal for reprogramming of cardiac gene expression.

ischemia-reperfusion; cardiac contractility; messenger ribonucleic acid; protein kinase C; rat

This article has been cited by other articles:

				N Yamashita, G F Baxter, and D M Yellon Exercise directly enhances myocardial tolerance to ischaemia-reperfusion injury in the rat through a protein kinase C mediated mechanism Heart, March 1, 2001; 85(3): 331 - 336. [Abstract] [Full Text]

				N. Hoque, M. A. Cook, and M. Karmazyn Inhibition of alpha 1-Adrenergic-Mediated Responses in Rat Ventricular Myocytes by Adenosine A1 Receptor Activation: Role of the KATP Channel J. Pharmacol. Exp. Ther., August 1, 2000; 294(2): 770 - 777. [Abstract] [Full Text]